Tandem Diabetes Care has patented a method and system for monitoring temperature in an ambulatory infusion pump during inductive charging to prevent damage to temperature-sensitive components like insulin. Charging is adjusted or suspended based on temperature thresholds to protect the contents and components. GlobalData’s report on Tandem Diabetes Care gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Tandem Diabetes Care Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Tandem Diabetes Care, Wearable drug delivery devices was a key innovation area identified from patents. Tandem Diabetes Care's grant share as of January 2024 was 48%. Grant share is based on the ratio of number of grants to total number of patents.

Inductive charging method for ambulatory infusion pump with temperature monitoring

Source: United States Patent and Trademark Office (USPTO). Credit: Tandem Diabetes Care Inc

A newly granted patent (Publication Number: US11872368B2) outlines a method for managing the charging process of an ambulatory infusion pump equipped with a rechargeable battery. The method involves detecting when the pump is placed on an inductive charging device, initiating charging at a first rate, monitoring temperature values within the pump, and comparing them to predetermined thresholds related to the sensitivity of the medicament stored in the pump. If the temperature values are within acceptable limits, charging continues at the initial rate. However, if the temperature exceeds certain thresholds, the charging rate is adjusted accordingly to prevent negative effects on the medicament.

Furthermore, the patent details additional features such as providing notifications to the user regarding the charging status, suspending charging if necessary to protect the medicament, and prompting the user to check alignment of the pump on the charging device. By implementing these steps, the method aims to ensure the safe and efficient charging of the ambulatory infusion pump while safeguarding the integrity of the stored medicament. The patent also includes provisions for adjusting the charging rate based on real-time temperature monitoring within the pump, offering a comprehensive approach to managing the charging process in a healthcare setting.

To know more about GlobalData’s detailed insights on Tandem Diabetes Care, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.